VN Research & Consulting
 Like us on facebook  Follow us on twitter  Follow us on LinkedIn  IndiaNotes on Google Plus  IndiaNotes on Pinterest  IndiaNotes on Stumbleupon  Subscribe to our feeds

Stocks  A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
You are here: IndiaNotes >> Research & Analysis>> Companies
The company overview page of Torrent Pharmaceuticals Ltd. shows financial information like live prices and stock quotes and technical charts on BSE and NSE. It also lists discussions for Torrent Pharmaceuticals Ltd. It features the latest news, fundamental analysis and technical analysis for Torrent Pharmaceuticals Ltd.

*The share prices have been adjusted for stock splits and dividends

Stock Recommendations for Torrent Pharmaceuticals Ltd.

Torrent Pharma Q2FY18: Expanding domestic footprint with Unichem acquisition - Upgrade to ADD
Equirus Securities | 14 Nov, 2017
Torrent Pharmaceutical Limited‟s (TRP) 2QFY18 results were slightly below EE owing to a topline miss due to one-offs in Brazil. However, a stron...

Torrent Pharma Q2FY18: Muted Quarterly Show; Unichem Deal to Boost Domestic Volume
Reliance Securities | 14 Nov, 2017
Envisaging a healthy growth in India and Brazil businesses led by new launches and improvement in sale force productivity, we maintain our BUY recomme...

Torrent Pharmaceuticals: Entering big league through this acquisition; Neutral
Motilal Oswal | 06 Nov, 2017
Deal to be EPS accretive in 3 years: Due to high interest cost, Unichem deal will take 3 years to become EPS accretive (additional interest cost burde...

Competitors for Torrent Pharmaceuticals Ltd.

Company Current Price Book Value P/E Ratio Market Cap
(Rs. Cr.)
Sharon Bio-Medicine Ltd. 6.90 -16.41 0.00 82.07
Welcure Drugs & Pharmaceuticals Ltd. 0.96 1.06 47.05 1.30
Lupin Ltd. 829.55 327.11 11.93 37,482.23
Ambalal Sarabhai Enterprises Ltd. 9.92 3.56 0.00 76.02
Parenteral Drugs (India) Ltd. 17.95 -33.64 0.00 53.52

Intraday Tips

What are technical calls?

View Stock Advice by: